^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    KIAA1217-RET fusion

    i
    Other names: KIAA1217, SKT, Sickle Tail Protein Homolog, ETL4, Likely Orthologue Of Mus Musculus Enhancer Trap Locus 4, RET, Ret Proto-Oncogene, Proto-Oncogene Tyrosine-Protein Kinase Receptor Ret, Cadherin-Related Family Member 16, Rearranged During Transfection, RET Receptor Tyrosine Kinase, Cadherin Family Member 12, Proto-Oncogene C-Ret, CDHF12, CDHR16, PTC, Ret Proto-Oncogene (Multiple Endocrine Neoplasia And Medullary Thyroid Carcinoma 1, Hirschsprung Disease), Multiple Endocrine Neoplasia And Medullar
    Entrez ID:
    5979; 56243
    Related biomarkers:
    Expression
    Mutation
    CNA
    Fusion
    Others
    over1year
    Bronchial salivary gland-type intraductal carcinoma with KIAA1217::RET gene fusion composed of intercalated and oncocytic components. (PubMed, Virchows Arch)
    In the present case, we detected KIAA1217::RET fusion via DNA-based next-generation sequencing (NGS) and RT-PCR, which established the diagnosis of IC at a molecular level. The present case expands the categories of bronchopulmonary salivary gland-type tumors.
    Journal
    |
    HER-2 (Human epidermal growth factor receptor 2) • RET (Ret Proto-Oncogene) • AR (Androgen receptor) • NKX2-1 (NK2 Homeobox 1) • SOX10 (SRY-Box 10) • KIAA1217 (KIAA1217) • TP63 (Tumor protein 63) • ANO1 (Anoctamin 1) • GATA3 (GATA binding protein 3) • NAPSA (Napsin A Aspartic Peptidase)
    |
    RET fusion • KIAA1217-RET fusion